Testing a zinc oxide device for securing catheters in hospitalized adults
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial
NA · Hospital Arnau de Vilanova · NCT06770374
This study is testing whether a zinc oxide adhesive can help keep catheters in place and reduce problems for adults in the hospital who need catheterization.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital Arnau de Vilanova (other) |
| Locations | 2 sites (Lleida, Catalonia and 1 other locations) |
| Trial ID | NCT06770374 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a zinc oxide adhesive securement device in reducing complications associated with midline catheters (MLC) and peripherally inserted central catheters (PICC) in hospitalized adult patients. Participants will be randomly assigned to receive either a zinc oxide or silicone adhesive device for catheter fixation. The aim is to determine if the zinc oxide device can lower the incidence of catheter dislodgement, skin injuries, and other related complications. The study will involve patients who require catheterization and will be monitored for outcomes related to catheter fixation.
Who should consider this trial
Good fit: Ideal candidates are hospitalized adults requiring a midline catheter or PICC for at least 7 days.
Not a fit: Patients with a known allergy to zinc oxide will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce catheter-related complications and improve patient comfort and safety.
How similar studies have performed: While similar studies have explored adhesive devices, the specific use of a zinc oxide device for this purpose is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * requiring cannulation of a midline catheter or a PICC * who accepted and signed the informed consent voluntarily * with an inpatient unit admission of minimum 7 days Exclusion Criteria: \- patients with a known allergy to zinc oxide
Where this trial is running
Lleida, Catalonia and 1 other locations
- Arnau de Vilanova Hospital — Lleida, Catalonia, Spain (RECRUITING)
- Hospital Universitari Arnau de Vilanova — Lleida, Catalonia, Spain (COMPLETED)
Study contacts
- Study coordinator: Padilla-Nula F PhD candidate, Nurse
- Email: FPADILLA@gencat.cat
- Phone: + 34 973 24 81 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Vascular Access Complication, Skin and Subcutaneous Tissue Disorders, Phlebitis, Pain, Catheters, Vascular Access Devices, Catheter-Related Infections, Nurse Specialists